Dissimilar Attenuation of Candida albicans Virulence Properties by Human Immunodeficiency Virus Type 1 Protease Inhibitors

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Tim R. Mosmann · Journal of Immunological Methods · 1983 · 55.6K citations

Life Sciences, Cell Biology, Apoptosis +14

Active human immunodeficiency virus protease is required for viral infectivity.

Nancy E. Kohl, Emilio A. Emini, William A. Schleif et al. · Proceedings of the National Academy of Sciences · 1988 · 1.3K citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Oral Candidiasis in High-Risk Patients as the Initial Manifestation of the Acquired Immunodeficiency Syndrome

Robert S. Klein, Carol Harris, Catherine B. Small et al. · New England Journal of Medicine · 1984 · 864 citations

Life Sciences, Immunology, Infectious Diseases +17

L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor

Bruce D. Dorsey, Rhonda B. Levin, Joseph P. Vacca et al. · Journal of Medicinal Chemistry · 1994 · 411 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.

S Seelmeier, Heike Schmidt, Vito Türk et al. · Proceedings of the National Academy of Sciences · 1988 · 326 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16